Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins

Coronavirus disease 19 (COVID-19) is a severe acute respiratory syndrome caused by SARS-CoV-2 (2019-nCoV). While no drugs have yet been approved to treat this disease, small molecules effective against other viral infections are under clinical evaluation for therapeutic abatement of SARS-CoV-2 infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramaniam, Meenakshisundaram, Reis, Robert J. Shmookler
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ChemRxiv 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263767/
https://www.ncbi.nlm.nih.gov/pubmed/32511290
http://dx.doi.org/10.26434/chemrxiv.12084822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263767/
https://www.ncbi.nlm.nih.gov/pubmed/32511290
http://dx.doi.org/10.26434/chemrxiv.12084822

Ejemplares similares